INTERNIST-NEFROLOOG DR. ISABELLE DEVOLDER
0691.777.868 · rovalta.com · 25/09/2026
INTERNIST-NEFROLOOG DR. ISABELLE DEVOLDER
Financial year 2025 · Closed on 30/12/2025
Overview
Identity
Source · BCE/KBOINTERNIST-NEFROLOOG DR. ISABELLE DEVOLDER is a Private limited company incorporated in 2018. Its registered office is in Knokke-Heist.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0691.777.868
- Incorporation
- 06/03/2018
- Legal form
- Private limited company
- Registered office
- Lippenslaan 70 box 3
8300 Knokke-Heist · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/12/2025
Financials
Source · NBB, 8 filingsTrend over 8 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 260,8 k € | +57.7% | 165,4 k € | -22.3% | 213 k € | +88.7% | 112,9 k € | -12.9% | 129,6 k € |
| EBITDA | 259,4 k € | +58.0% | 164,2 k € | -22.3% | 211,2 k € | +90.5% | 110,9 k € | -12.0% | 126,1 k € |
| Operating result | 236 k € | +69.8% | 139 k € | -26.2% | 188,2 k € | +114% | 88,1 k € | -15.3% | 104 k € |
| Net result | 174,8 k € | +72.5% | 101,3 k € | -27.1% | 139 k € | +112% | 65,7 k € | -18.2% | 80,4 k € |
| Balance sheet | |||||||||
| Equity | 18,6 k € | 0.0% | 18,6 k € | -34.6% | 28,5 k € | -84.5% | 183,1 k € | -35.6% | 284,3 k € |
| Total assets | 241,8 k € | +6.1% | 227,9 k € | -38.4% | 370 k € | +16.9% | 316,5 k € | -10.5% | 353,6 k € |
| Cash | 103,3 k € | -9.0% | 113,4 k € | -1.6% | 115,3 k € | +51.7% | 76 k € | +106% | 36,8 k € |
| Debts | 223,2 k € | +6.6% | 209,3 k € | -38.7% | 341,5 k € | +156% | 133,5 k € | +92.7% | 69,3 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/12/20251 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
Lippenslaan 70 8300 Knokke-Heist| Company | CBE no. |
|---|---|
EYE DESIGNERS● Active | 0468.245.823 |
| 0563.483.985 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 30/12/2025 | 30/12/2024 | 30/12/2023 | 30/12/2022 | 30/12/2021 | 31/12/2020 |
| Length of the financial year | 13 months | 13 months | 13 months | 13 months | 12 months | 12 months |
| Filing date | 16/02/2026 | 20/03/2025 | 02/04/2024 | 20/04/2023 | 11/03/2022 | 25/03/2021 |
| General meeting | 05/02/2026 | 20/03/2025 | 28/03/2024 | 17/04/2023 | 10/03/2022 | 25/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/12/2025 | 05/02/2026 | 16/02/2026 | Dutch | |
| Micro model | 30/12/2024 | 20/03/2025 | 20/03/2025 | Dutch | |
| Micro model | 30/12/2023 | 28/03/2024 | 02/04/2024 | Dutch | |
| Micro model | 30/12/2022 | 17/04/2023 | 20/04/2023 | Dutch | |
| Micro model | 30/12/2021 | 10/03/2022 | 11/03/2022 | Dutch | |
| Micro model | 31/12/2020 | 25/03/2021 | 25/03/2021 | Dutch | |
| Micro model | 31/12/2019 | 25/03/2020 | 05/09/2022 | Dutch | |
| Micro model | 31/12/2018 | 18/03/2019 | 25/03/2019 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/12/20251 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025174,8 k €↑
- 2024Annual accounts 2024101,3 k €↓
- 2023Annual accounts 2023139 k €↑
- 2022Annual accounts 202265,7 k €↓
- 2021Annual accounts 202180,4 k €↓
- 2020Annual accounts 2020161,6 k €↓
- 2019Annual accounts 2019240,4 k €↑
- 2018Annual accounts 2018235,8 k €
- 06/03/2018IncorporationPrivate limited company